Vun-Sin Lim: A Perspective article on the MARS2 trial by Eric Lim, et al.
Vun-Sin Lim, Managing Editor of the Journal of Thoracic Oncology, shared a post by JTO and JTO CRR on X, about a paper by Eric Lim et al. published in the Journal of Thoracic Oncology.
“A Perspective article on the MARS2 trial by Lim et al. is published online in JTO and JTO CRR.”
“A Perspective on the MARS2 Trial”
Authors: Eric Lim, Isabelle Opitz, Gavitt Woodard, Raphael Bueno, Marc de Perrot, Raja Flores, Ritu Gill, David Jablons, Harvey Pass.
Quoting JTO and JTO CRR’s post:
“Results from the MARS2 trial reported that patients who received extended pleurectomy decortication and chemotherapy had worse survival rates than those who received chemotherapy alone. The MARS2 results are controversial and the debate continues in JTO.”
More posts featuring Vun-Sin Lim.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023